Comparative efficacy and safety of probiotics for the treatment of irritable bowel syndrome: a systematic review and network meta-analysis protocol
Introduction Irritable bowel syndrome (IBS) is a common chronic functional gastrointestinal disorder affecting approximately 10% to 25% of the adult population. A large number of clinical trials have been conducted to evaluate the efficacy of probiotics for IBS but the results were inconsistent. Pre...
Saved in:
| Main Authors: | Man Yang, Yuanyuan Yu, Ping-Guang Lei, Jinqiu Yuan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/12/e027376.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Irritable bowel syndrome in children: probiotics and vitamins
by: A. V. Gorelov, et al.
Published: (2021-06-01) -
The Irritable Bowel Syndrome
by: N.B. Hershfield
Published: (1988-01-01) -
Irritable Bowel Syndrome
by: Per G. Farup, et al.
Published: (2012-01-01) -
NANOVESICLES IN THE GUT–BRAIN AXIS: INSIGHTS FROM PROBIOTIC SUPPLEMENTATION IN IRRITABLE BOWEL SYNDROME
Published: (2025-08-01) -
Possibilities of modern probiotic therapy in the treatment of patients with post-infectious irritable bowel syndrome
by: V. A. Akhmedov, et al.
Published: (2022-02-01)